Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Hamstra

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Molecular Imaging|September 7, 2006
Imaging of proteolytic activity using a conditional cell surface receptorMahaveer Swaroop Bhojani, Daniel A Hamstra, Daniel C Chang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2016
Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trialsOrazio Caffo, Catherine Thompson, Maria De Santis, et al.
Practical Radiation Oncology|June 4, 2014
Combining prostate-specific antigen nadir and time to nadir allows for early identification of patients at highest risk for development of metastasis and death following salvage radiation therapyWilliam C Jackson, Skyler B Johnson, Benjamin Foster, et al.
Medical Physics|February 24, 2018
Changes in prostate orientation due to removal of a Foley catheterDale W Litzenberg, Daniel G Muenz, Paul G Archer, et al.
BJU International|September 22, 2015
Symptom burden and information needs in prostate cancer survivors: a case for tailored long-term survivorship careJennifer K Bernat, Daniela A Wittman, Sarah T Hawley, et al.
Neoplasia (New York, N.Y.)|April 25, 2016
MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent MannerFelix Y Feng, Yu Zhang, Vishal Kothari, et al.
Clinical and Translational Radiation Oncology|July 11, 2022
Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatmentZachary A Seymour, Stephanie Daignault-Newton, P W McLaughlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Evaluation of D-methionine as a novel oral radiation protector for prevention of mucositisSaleha B Vuyyuri, Daniel A Hamstra, Divya Khanna, et al.
European Urology|May 26, 2015
Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical ProstatectomyWilliam C Jackson, Matthew J Schipper, Skyler B Johnson, et al.
International Journal of Radiation Oncology, Biology, Physics|April 5, 2011
Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trialsDaniel A Hamstra, Kyounghwa Bae, Miljenko V Pilepich, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Molecular Imaging|September 7, 2006
Imaging of proteolytic activity using a conditional cell surface receptorMahaveer Swaroop Bhojani, Daniel A Hamstra, Daniel C Chang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2016
Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trialsOrazio Caffo, Catherine Thompson, Maria De Santis, et al.
Practical Radiation Oncology|June 4, 2014
Combining prostate-specific antigen nadir and time to nadir allows for early identification of patients at highest risk for development of metastasis and death following salvage radiation therapyWilliam C Jackson, Skyler B Johnson, Benjamin Foster, et al.
Medical Physics|February 24, 2018
Changes in prostate orientation due to removal of a Foley catheterDale W Litzenberg, Daniel G Muenz, Paul G Archer, et al.
BJU International|September 22, 2015
Symptom burden and information needs in prostate cancer survivors: a case for tailored long-term survivorship careJennifer K Bernat, Daniela A Wittman, Sarah T Hawley, et al.
Neoplasia (New York, N.Y.)|April 25, 2016
MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent MannerFelix Y Feng, Yu Zhang, Vishal Kothari, et al.
Clinical and Translational Radiation Oncology|July 11, 2022
Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatmentZachary A Seymour, Stephanie Daignault-Newton, P W McLaughlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Evaluation of D-methionine as a novel oral radiation protector for prevention of mucositisSaleha B Vuyyuri, Daniel A Hamstra, Divya Khanna, et al.
European Urology|May 26, 2015
Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical ProstatectomyWilliam C Jackson, Matthew J Schipper, Skyler B Johnson, et al.
International Journal of Radiation Oncology, Biology, Physics|April 5, 2011
Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trialsDaniel A Hamstra, Kyounghwa Bae, Miljenko V Pilepich, et al.
Pageof 13